MC-FludT.18 QT

Hämatologische Neoplasien
Transplantationsstudien (Tx Studien), Myelodysplastisches Syndrom (MDS), Akute myeloische Leukämie (AML)
Systemtherapie 1. Linie (metastasierte Erkrankung / Hämatologie)
Phase I trial to assess the cardiac safety of treosulfan-based conditioning therapy in subjects with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation
Phase I trial to assess the cardiac safety of treosulfan-based conditioning therapy in subjects with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation